Clinical Trial
Hamada Hamid Altalib
A 57-Week, Multicenter, Active-treatment, Open-label Extension Trial of CVL-865 as Adjunctive Therapy in Adults With Drug-Resistant Focal Onset Seizures
- Ages18 years - 75 years
- GenderBoth